Additionally, Kanbay et al. observed a significant association between high serum sclerostin levels and both fatal and nonfatal cardiovascular events in ND-CKD patients, even after multiple statistical adjustments (p < 0.001) [70]. Here, SOST is linked to chronic kidney disease.